Potential uses of omberacetam (Noopept©) in the early prevention and management of cognitive impairment
О. Н. Ткачева(Pirogov Russian National Research Medical University), М. В. Метлина(Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency), С. А. Бернс, Sergey Mosolov(Ministry of Health), E. А. Mkhitaryan(Pirogov Russian National Research Medical University), И. В. Колыхалов, О. М. Драпкина(National Research Center for Preventive Medicine), Yu. V. Vakhitova(Pirogov Russian National Research Medical University), М. А. Чердак(Pirogov Russian National Research Medical University), N. N. Koberskaya(Sechenov University), С. Б. Середенин(Institute of Pharmacology), I. D. Strazhesko(Pirogov Russian National Research Medical University), О. С. Зайцев(Russian Medical Academy of Continuous Professional Education)
Cited by 0
Related Papers
Disorders of lipid metabolism. Clinical Guidelines 2023
|Russian Journal of Cardiology|2023|195
Clinical guidelines on frailty
|Russian Journal of Geriatric Medicine|2020|187
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
|Obesity and metabolism|2021|123
Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association
|Russian Journal of Gastroenterology Hepatology Coloproctology|2016|122
2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines
|CARDIOVASCULAR THERAPY AND PREVENTION|2022|119